Skip to content

Observational Study of Optical Correction for Strabismic Amblyopia in Children 3 to <7 Years Old

An Observational Study of Optical Correction for Strabismic Amblyopia in Children 3 to <7 Years Old

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00669539
Acronym
ATS13
Enrollment
156
Registered
2008-04-30
Start date
2008-05-31
Completion date
2010-12-31
Last updated
2016-07-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Amblyopia

Keywords

Amblyopia associated with strabismus, Refractive error

Brief summary

This study will evaluate the effectiveness of refractive correction alone for the treatment of previously untreated strabismic or combined-mechanism amblyopia in children 3 to \<7 years old with visual acuity of 20/40 to 20/400

Detailed description

This study will evaluate the effectiveness of refractive correction alone for the treatment of previously untreated strabismic or combined-mechanism amblyopia in children 3 to \<7 years old with visual acuity of 20/40 to 20/400. A recently completed PEDIG study (ATS5) found that in 3 to \< 7-year-old children with previously untreated anisometropic amblyopia, refractive correction alone improved visual acuity by 2 or more lines in 77% of the patients and amblyopia resolved in at least one third of the patients. These results supported previous observations from retrospective and pilot studies as well as Stewart et al's prospective report on 18 children with anisometropic amblyopia whose visual acuity improved after treatment with spectacle correction only. Improvement in amblyopic eye visual acuity from treatment with optimum refractive correction in cases of anisometropic amblyopia is plausible because the refractive correction treats the underlying amblyogenic condition (i.e., uncorrected unequal refractive error) by providing retinal images of more similar clarity, size, and contrast. Elimination of the dissimilar retinal images, which may act as barriers to normal visual input, allows the amblyopic eye to receive appropriate visual stimulation. In contrast, visual acuity improvement with refractive correction alone in cases of amblyopia associated with strabismus is not expected to occur when the refractive correction does not completely eliminate the strabismus and restore fusion. In such cases, the underlying amblyogenic factor of a manifest ocular deviation remains; consequently, active cortical inhibition is presumably still present. Nonetheless, Stewart and colleagues recently reported finding gains in amblyopic eye visual acuity of children with strabismic and combined-mechanism amblyopia after a period of treatment with refractive correction alone. The PEDIG also observed this to occur in a subgroup of children with previously untreated strabismic and combined-mechanism amblyopia in a recent study. Amblyopic eye acuity improved by \>= 2 lines from spectacle-corrected baseline acuity in 9 (75%; 95% CI = 43% - 95%) of the 12 patients with strabismic amblyopia and in 9 (69%, 95% CI = 39% - 91%) of the 13 patients with combined-mechanism amblyopia. Mean change from baseline to maximum improvement was 2.2 +- 1.8 and 2.6 +- 2.0 lines, respectively. These results are similar to those of Stewart and colleagues who reported visual acuity improvement averaging 3.0 lines in 16 children with strabismic amblyopia and 1.9 lines in 31 children with combined-mechanism amblyopia. Although our results support the suggestion of Stewart et al. that strabismic amblyopia can improve with spectacle correction alone, they are not conclusive because both studies had small numbers of patients. Also, our classification of strabismus was based on alignment without refractive correction. Thus, a larger controlled study is needed to confirm or refute these findings in patients with strabismic and combined-mechanism amblyopia. The ideal study design to answer the question of whether spectacles alone can significantly improve amblyopic eye visual acuity in strabismic children is a randomized trial with a control group who does not receive optical correction. However, most pediatric eye care providers would be reluctant to randomize esotropic children with hyperopic refractive error to a control group of no optical correction because of the likelihood of some children having accommodative esotropia, which would necessitate that hyperopic spectacles be prescribed. The number of esotropic amblyopes without an accommodative component is sufficiently few to make a randomized trial not feasible. Therefore, we have chosen to perform an observational study with a large number of children with pure strabismic and combined-mechanism amblyopia in order to evaluate the effect of refractive correction in this population of patients.

Interventions

None listed

Sponsors

National Eye Institute (NEI)
CollaboratorNIH
Jaeb Center for Health Research
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
3 Years to 6 Years
Healthy volunteers
No

Inclusion criteria

* Age 3 to \<7 years old * Able to perform visual acuity testing using the ATS single-surround HOTV protocol * Amblyopia associated with strabismus (comitant or incomitant) with or without anisometropia \*At least one of the following criteria must be met: * Heterotropia at distance and/or near fixation on examination (without spectacles) * History of strabismus surgery (or botulinum toxin extraocular muscle injection) * Documented history of strabismus that is no longer present (and which in the judgment of the investigator is the cause of amblyopia) * Visual acuity measured in each eye according to the protocol procedures that meet the following criteria: * Amblyopic eye 20/40 to 20/400 inclusive * Sound eye \>=20/40 * Inter-eye acuity difference \>= 3 logMAR lines (i.e., amblyopic eye acuity at least 3 logMAR lines worse than sound eye acuity) * No previous spectacle correction * Refractive error meeting at least 1 of the following criteria: \>= 1.00D of astigmatism in the amblyopic eye, \>= 1.00D spherical equivalent anisometropia, or \>= +2.00D spherical equivalent hyperopia in either eye. * Investigator wishes to prescribe spectacles to correct refractive error * Nystagmus per se does not exclude the patient if the above visual acuity criteria are met * Ocular examination within 2 months prior to enrollment * Cycloplegic refraction within 2 months prior to enrollment * No myopia = -0.25D spherical equivalent) * Parent understands protocol and is willing to accept treatment * Parent has home phone (or access to phone) and is willing to be contacted by Jaeb Center staff * Relocation outside of area of an active ATS site within next 6 months not anticipated

Exclusion criteria

* Prior amblyopia treatment * Current vision therapy or orthoptics * Ocular cause for reduced visual acuity * Prior intraocular or refractive surgery * Strabismus surgery planned in the 9 weeks following the Baseline Visit

Design outcomes

Primary

MeasureTime frameDescription
Mean Amblyopic Eye Visual Acuity Improvement With SpectaclesEnrollment to 18 WeeksAcuity is measured in each eye using the Amblyopia Treatment Study (ATS) visual acuity testing protocol at baseline and at 18wks resulting in a Snellen acuity score that can range from 20/16 to 20/800. The score is converted to logMAR (log of min angle of resolution) for statistical analysis, and a difference between the scores is calculated. A positive difference indicates acuity was better at 18wks than at baseline; a negative difference indicates acuity was worse at 18wks than at baseline.

Countries

United States

Participant flow

Participants by arm

ArmCount
Combined-Mechanism Amblyopia
Chilren with strabismus and anisometropia who were prescribed refractive error correction with spectacles. The eye with worse visual acuity was labeled the amblyopic eye; the eye with better visual acuity was labeled the fellow eye. All analyses included only 1 observation per participant.
94
Strabismus-Only Amblyopia
Chilren with pure strabismus who were prescribed refractive error correction with spectacles. The eye with worse visual acuity was labeled the amblyopic eye; the eye with better visual acuity was labeled the fellow eye. All analyses included only 1 observation per participant.
52
Total146

Baseline characteristics

CharacteristicTotalCombined-Mechanism AmblyopiaStrabismus-Only Amblyopia
Age, Continuous4.9 years
STANDARD_DEVIATION 1.1
5.1 years
STANDARD_DEVIATION 1.1
4.7 years
STANDARD_DEVIATION 1
Age, Customized
3 to <4 years
30 participants14 participants16 participants
Age, Customized
4 to <5 years
51 participants35 participants16 participants
Age, Customized
5 to <6 years
34 participants19 participants15 participants
Age, Customized
6 to <7 years
31 participants26 participants5 participants
Distance Visual Acuity Amblyopic Eye0.64 logMAR
STANDARD_DEVIATION 0.24
0.64 logMAR
STANDARD_DEVIATION 0.24
0.65 logMAR
STANDARD_DEVIATION 0.26
Distance Visual Acuity in Fellow Eye0.12 logMAR
STANDARD_DEVIATION 0.12
0.09 logMAR
STANDARD_DEVIATION 0.12
0.16 logMAR
STANDARD_DEVIATION 0.11
Interocular Difference in Distance Visual Acuity5.2 logMAR lines
STANDARD_DEVIATION 2.3
5.4 logMAR lines
STANDARD_DEVIATION 2.4
4.9 logMAR lines
STANDARD_DEVIATION 2.2
Ocular Alignment
0 prism diopters (better)
37 participants23 participants14 participants
Ocular Alignment
1-8 prism diopters
63 participants48 participants15 participants
Ocular Alignment
>8 prism diopters (worse)
46 participants23 participants23 participants
Ocular Alignment7.6 prism diopters
STANDARD_DEVIATION 10.6
5.7 prism diopters
STANDARD_DEVIATION 7
11.1 prism diopters
STANDARD_DEVIATION 14.5
Race/Ethnicity, Customized
Asian
3 participants3 participants0 participants
Race/Ethnicity, Customized
Black/Aftican American
11 participants4 participants7 participants
Race/Ethnicity, Customized
Hispanic
11 participants4 participants7 participants
Race/Ethnicity, Customized
More than one race
1 participants0 participants1 participants
Race/Ethnicity, Customized
Unknown/not reported
1 participants1 participants0 participants
Race/Ethnicity, Customized
White
119 participants82 participants37 participants
Sex: Female, Male
Female
69 Participants46 Participants23 Participants
Sex: Female, Male
Male
77 Participants48 Participants29 Participants
Spherical Equivalent Refractive Error in Amblyopic Eye
0 to <+1.00 diopters (better)
2 participants1 participants1 participants
Spherical Equivalent Refractive Error in Amblyopic Eye
+1.00 to <+2.00 diopters
11 participants8 participants3 participants
Spherical Equivalent Refractive Error in Amblyopic Eye
+2.00 to <+3.00 diopters
22 participants5 participants17 participants
Spherical Equivalent Refractive Error in Amblyopic Eye
+3.00 to <+4.00 diopters
27 participants17 participants10 participants
Spherical Equivalent Refractive Error in Amblyopic Eye
>=+4.00 diopters (worse)
84 participants63 participants21 participants
Spherical Equivalent Refractive Error in Amblyopic Eye4.31 diopters
STANDARD_DEVIATION 1.83
4.65 diopters
STANDARD_DEVIATION 1.79
3.69 diopters
STANDARD_DEVIATION 1.74
Spherical Equivalent Refractive Error in Fellow Eye
0 to <+1.00 diopters (better)
12 participants11 participants1 participants
Spherical Equivalent Refractive Error in Fellow Eye
+1.00 to <+2.00 diopters
29 participants24 participants5 participants
Spherical Equivalent Refractive Error in Fellow Eye
+2.00 to <+3.00 diopters
49 participants32 participants17 participants
Spherical Equivalent Refractive Error in Fellow Eye
+3.00 to <+4.00 diopters
21 participants9 participants12 participants
Spherical Equivalent Refractive Error in Fellow Eye
>=+4.00 diopters (worse)
35 participants18 participants17 participants
Spherical Equivalent Refractive Error in Fellow Eye2.90 diopters
STANDARD_DEVIATION 1.65
2.61 diopters
STANDARD_DEVIATION 1.6
3.44 diopters
STANDARD_DEVIATION 1.62

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
0 / 940 / 52
serious
Total, serious adverse events
0 / 940 / 52

Outcome results

Primary

Mean Amblyopic Eye Visual Acuity Improvement With Spectacles

Acuity is measured in each eye using the Amblyopia Treatment Study (ATS) visual acuity testing protocol at baseline and at 18wks resulting in a Snellen acuity score that can range from 20/16 to 20/800. The score is converted to logMAR (log of min angle of resolution) for statistical analysis, and a difference between the scores is calculated. A positive difference indicates acuity was better at 18wks than at baseline; a negative difference indicates acuity was worse at 18wks than at baseline.

Time frame: Enrollment to 18 Weeks

Population: Primary analysis includes only patients who completed the 18 week exam. No imputation was done if missed exam; analysis followed the intent to treat principle.

ArmMeasureValue (MEAN)Dispersion
Combined-Mechanism AmblyopiaMean Amblyopic Eye Visual Acuity Improvement With Spectacles2.3 logMAR unitsStandard Deviation 1.8
Strabismus-Only AmblyopiaMean Amblyopic Eye Visual Acuity Improvement With Spectacles3.2 logMAR unitsStandard Deviation 1.9

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026